Evgeny Nikolsky Appointed as JTI Romania, Moldova, Bulgaria GM

News by 2FIRSTS.ai

Feb.22.2024

Evgeny Nikolsky Appointed as JTI Romania, Moldova, Bulgaria GM

Evgeny Nikolsky appointed as new general manager of JTI in Romania, Moldova, and Bulgaria, following successful career progression.

Recently, according to a statement released by Japan Tobacco International (JTI), Evgeny Nikolsky has been appointed as the new General Manager of JTI in Romania, Moldova, and Bulgaria.

Nikolsky joined JTI in 2001 and has since advanced his career and professional skills in brand and trade marketing. In 2009, he became the country sales director. In 2014, he managed city distributors in Russia before becoming the sales director for JTI Russia. In 2016, he returned to Kazakhstan and since 2018, he has also been coordinating JTI's activities in Central Asia and Mongolia.

Niculescu expressed his excitement for the appointment, stating, "I am pleased to have the opportunity to live and work in Romania. JTI has been operating in this country for 30 years, holding over 28% market share and introducing the e-cigarette product Logic Compact in recent years.

Former CEO Mark Rock will continue to lead JTI Germany.

References:

[1] Evgeny Nikolsky is the new General Manager of JTI Romania

Also Read:

[1] VPR Brands Appoints TPB Canada as Exclusive Distributor for HoneyStick

[2] Wade Huckabee Appointed Senior Vice President of BAT's Subsidiary

[3] Dr. Moira Gilchrist Promoted as PMI's Chief Communication Officer

[4] Kaival Brands Appoints James W. Dobbins as General Counsel

[5] Navaneel Kar Appointed as Director General of IPM India

#Europe #E-cigarettes #Romania #JTI #Bulgaria #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations

New Zealand’s High Alert drug harm monitoring system has issued a public High Alert warning after multiple hospitalisations linked to illicit vape pods containing the anaesthetic etomidate. Known on the street as space oil, k-pods, or eto, these vapes were first detected in January 2025. Customs has since seized additional samples, and clinics nationwide report rising cases of poisoning and hypoglycaemia.

Nov.04 by 2FIRSTS.ai

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.

Nov.24 by 2FIRSTS.ai

1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly

Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.